{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:42:47Z","timestamp":1782754967903,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s11908-007-0016-1","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T12:30:22Z","timestamp":1176899422000},"page":"7-13","source":"Crossref","is-referenced-by-count":41,"title":["Macrolide immunomodulation of chronic respiratory diseases"],"prefix":"10.1007","volume":"9","author":[{"given":"Daniel P.","family":"Healy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,4,17]]},"reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11882-004-0058-5","volume":"4","author":"D.A. Beuther","year":"2004","unstructured":"Beuther DA, Martin RJ: Antibiotics in asthma. Curr Allergy Asthma Rep 2004, 4:132\u2013138.","journal-title":"Curr Allergy Asthma Rep"},{"key":"16_CR2","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","volume":"157","author":"S. Kudoh","year":"1998","unstructured":"Kudoh S, Azuma A, Yamamoto M, et al.: Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998, 157:1829\u20131832.","journal-title":"Am J Respir Crit Care Med"},{"key":"16_CR3","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/AAC.40.10.2271","volume":"40","author":"K. Tateda","year":"1996","unstructured":"Tateda K, Ishii Y, Matsumoto T, et al.: Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrob Agents Chemother 1996, 40:2271\u20132275.","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","volume":"37","author":"L.A. Mandell","year":"2003","unstructured":"Mandell LA, Bartlett JG, Dowell SF, et al.: Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003, 37:1405\u20131433.","journal-title":"Clin Infect Dis"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","volume":"55","author":"G.W. Amsden","year":"2005","unstructured":"Amsden GW: Anti-inflammatory effects of macrolidesan underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother 2005, 55:10\u201321.","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl2","key":"16_CR6","doi-asserted-by":"crossref","first-page":"62S","DOI":"10.1378\/chest.125.2_suppl.62S","volume":"125","author":"D.J. Wozniak","year":"2004","unstructured":"Wozniak DJ, Keyser R: Effects of subinhibitory concentrations of macrolide antibiotics on Pseudomonas aeruginosa. Chest 2004, 125(Suppl 2):62S\u201369S.","journal-title":"Chest"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.36.9.1922","volume":"36","author":"Y. Hirakata","year":"1992","unstructured":"Hirakata Y, Kaku M, Mizukane R, et al.: Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992, 36:1922\u20131927.","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/jac\/dkf013","volume":"49","author":"K. Yanagihara","year":"2002","unstructured":"Yanagihara K, Tomono K, Imamura Y, et al.: Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. J Antimicrob Chemother 2002, 49:867\u2013870.","journal-title":"J Antimicrob Chemother"},{"key":"16_CR9","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/AAC.44.10.2869-2872.2000","volume":"44","author":"K. Kawamura-Sato","year":"2000","unstructured":"Kawamura-Sato K, Iinuma Y, Hasegawa T, et al.: Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrob Agents Chemother 2000, 44:2869\u20132872.","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR10","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.otc.2005.08.002","volume":"38","author":"A. Cervin","year":"2005","unstructured":"Cervin A, Wallwork B: Anti-inflammatory effects of macrolide antibiotics in the treatment of chronic rhinosinusitis. Otolaryngol Clin N Amer 2005, 38:1339\u20131350.","journal-title":"Otolaryngol Clin N Amer"},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1164\/ajrccm.155.6.9196110","volume":"155","author":"B.K. Rubin","year":"1997","unstructured":"Rubin BK, Druce H, Ramirez OE, et al.: Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis. Am J Respir Crit Care Med 1997, 155:2018\u20132023.","journal-title":"Am J Respir Crit Care Med"},{"key":"16_CR12","first-page":"227","volume":"6","author":"M. Shinkai","year":"2005","unstructured":"Shinkai M, Rubin BK: Macrolides and airway inflammation in children. Paed Resp Rev 2005, 6:227\u2013235.","journal-title":"Paed Resp Rev"},{"issue":"Suppl2","key":"16_CR13","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1378\/chest.125.2_suppl.41S","volume":"125","author":"J. Tamaoki","year":"2004","unstructured":"Tamaoki J: The effects of macrolides on inflammatory cells. Chest 2004, 125(Suppl 2):41S\u201351S.","journal-title":"Chest"},{"issue":"Suppl9A","key":"16_CR14","first-page":"5S","volume":"117","author":"J. Tamaoki","year":"2004","unstructured":"Tamaoki J, Kadota J, Takizawa H: Clinical implications of the immunomodulatory effects of macrolides. Am J Med 2004, 117(Suppl 9A):5S\u201311S.","journal-title":"Am J Med"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/joc.2001.13.1.3","volume":"13","author":"M.T. Labro","year":"2001","unstructured":"Labro MT, Abdelghaffar H: Immunomodulation by macrolide antibiotics. J Chemother 2001, 13:3\u20138.","journal-title":"J Chemother"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dkf008","volume":"49","author":"T. Kikuchi","year":"2002","unstructured":"Kikuchi T, Hagiwara K, Honda Y, et al.: Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappaB transcription factors. J Antimicrob Chemother 2002, 49:745\u2013755.","journal-title":"J Antimicrob Chemother"},{"key":"16_CR17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkh309","volume":"54","author":"M.J. Schultz","year":"2004","unstructured":"Schultz MJ: Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimrob Chemother 2004, 54:21\u201328.","journal-title":"J Antimrob Chemother"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AAC.47.1.48-53.2003","volume":"47","author":"T. Yamaryo","year":"2003","unstructured":"Yamaryo T, Oishi K, Yoshimine H, et al.: Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother 2003, 47:48\u201353.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl9A","key":"16_CR19","first-page":"12S","volume":"117","author":"S. Kudoh","year":"2004","unstructured":"Kudoh S: Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases. Am J Med 2004, 117(Suppl 9A):12S\u201319S.","journal-title":"Am J Med"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/AAC.39.8.1688","volume":"39","author":"J. Tamaoki","year":"1995","unstructured":"Tamaoki J, Takeyama K, Tagaya E, et al.: Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections. Antimicrob Agents Chemother 1995, 39:1688\u20131690.","journal-title":"Antimicrob Agents Chemother"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2004.09.014","volume":"99","author":"G. Ferrara","year":"2005","unstructured":"Ferrara G, Losi M, Franco F, et al.: Macrolides in the treatment of asthma and cystic fibrosis. Respir Med 2005, 99:1\u201310.","journal-title":"Respir Med"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/thorax.57.3.212","volume":"57","author":"J. Wolter","year":"2002","unstructured":"Wolter J, Seeney S, Bell S, et al.: Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomized trial. Thorax 2002, 57:212\u2013216.","journal-title":"Thorax"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0140-6736(02)11081-6","volume":"360","author":"A. Equi","year":"2002","unstructured":"Equi A, Balfour-Lynn IM, Bush A, et al.: Long term azithromycin in children with cystic fibrosis: a randomized, placebo-controlled crossover trial. Lancet 2002, 360:978\u2013984.","journal-title":"Lancet"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","volume":"290","author":"L. Saiman","year":"2003","unstructured":"Saiman L, Marshall BC, Mayer-Hamblett N, et al.: Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2003, 290:1749\u20131756.","journal-title":"JAMA"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/thx.2005.057950","volume":"61","author":"A. Clement","year":"2006","unstructured":"Clement A, Tamalet A, Le Roux E, et al.: Long term effects of azithromycin in patients with cystic fibrosis: a double-blind, placebo-controlled trial. Thorax 2006, 61:895\u2013902.","journal-title":"Thorax"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0140-6736(05)79350-8","volume":"351","author":"E.L. Altschuler","year":"1998","unstructured":"Altschuler EL: Azithromycin, the multi-drug resistance protein, and cystic fibrosis. Lancet 1998, 351:1286.","journal-title":"Lancet"},{"key":"16_CR27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/clpt.1982.143","volume":"32","author":"S.J. Szefler","year":"1982","unstructured":"Szefler SJ, Brenner M, Jusko WJ, et al.: Dose-and time-related effects of troleandomycin on methylprednisolone elimination. Clin Pharmacol Ther 1982, 32:166\u2013171.","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl9A","key":"16_CR28","first-page":"2S","volume":"117","author":"B.K. Rubin","year":"2004","unstructured":"Rubin BK: Immunomodulatory properties of macrolides: overview and historical perspective. Am J Med 2004, 117(Suppl 9A):2S\u20134S.","journal-title":"Am J Med"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1046\/j.1365-2222.1999.00551.x","volume":"29","author":"T. Shoji","year":"1999","unstructured":"Shoji T, Yoshida S, Sakamoto H, et al.: Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma. Clin Exp Allergy 1999, 29:950\u2013956.","journal-title":"Clin Exp Allergy"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1081-1206(10)62409-X","volume":"84","author":"H. Amayasu","year":"2000","unstructured":"Amayasu H, Yoshida S, Ebana S: Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000, 84:594\u2013598.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.164.4.2011040","volume":"164","author":"P.N. Black","year":"2001","unstructured":"Black PN, Blasi F, Jenkins CR, et al.: Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001, 164:536\u2013541.","journal-title":"Am J Respir Crit Care Med"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1378\/chest.121.6.1782","volume":"121","author":"M. Kraft","year":"2002","unstructured":"Kraft M, Cassell GH, Pak J, Martin RJ: Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002, 121:1782\u20131788.","journal-title":"Chest"},{"issue":"Suppl9A","key":"16_CR33","first-page":"20S","volume":"117","author":"Y. Majima","year":"2004","unstructured":"Majima Y: Clinical implications of the immunomodulatory effects of macrolides on sinusitis. Am J Med 2004, 117(Suppl 9A):20S\u201325S.","journal-title":"Am J Med"},{"issue":"Suppl2","key":"16_CR34","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1378\/chest.125.2_suppl.52S","volume":"125","author":"M.H. Gotfried","year":"2004","unstructured":"Gotfried MH: Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004, 125(Suppl 2):52S\u201316S.","journal-title":"Chest"},{"issue":"Suppl2","key":"16_CR35","doi-asserted-by":"crossref","first-page":"70S","DOI":"10.1378\/chest.125.2_suppl.70S","volume":"125","author":"B.K. Rubin","year":"2004","unstructured":"Rubin BK, Henke MO: Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest 2004, 125(Suppl 2):70S\u201378S.","journal-title":"Chest"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0954-6111(03)00042-8","volume":"97","author":"J. Kadota","year":"2003","unstructured":"Kadota J, Mukae H, Ishii H, et al.: Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis. Respir Med 2003, 97:844\u2013850.","journal-title":"Respir Med"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1191\/1479972305cd066rs","volume":"2","author":"S.C. Bell","year":"2005","unstructured":"Bell SC, Senini SL, McCormack JG: Macrolides in cystic fibrosis. Chron Respir Dis 2005, 2:85\u201398.","journal-title":"Chron Respir Dis"},{"key":"16_CR38","first-page":"741","volume":"8","author":"R.A. Fecik","year":"2005","unstructured":"Fecik RA, Nguyen PL, Venkatraman L: Approaches to the synthesis of immunolides: selective immunomodulatory macroides for cystic fibrosis. Curr Opin Drug Discov Devel 2005, 8:741\u2013747.","journal-title":"Curr Opin Drug Discov Devel"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0016-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-007-0016-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0016-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:22:05Z","timestamp":1559420525000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-007-0016-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s11908-007-0016-1","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}